← Back to Search

Unknown

BGE-175 for Coronavirus

Phase 2
Waitlist Available
Led By Richard G Wilkerson, MD
Research Sponsored by BioAge Labs, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to voluntarily provide informed consent that is documented per local requirements
An understanding, ability, and willingness to fully comply with study procedures and restrictions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through day 57; at day 14, day 28 and day 57
Awards & highlights

Study Summary

This study is evaluating whether a drug may help treat people with a certain type of pneumonia.

Eligible Conditions
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through day 57; at day 14, day 28 and day 57
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through day 57; at day 14, day 28 and day 57 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of Participants Who Have Died or Progressed to Respiratory Failure
Secondary outcome measures
Daily Ratio of Oxygen Saturation (SpO2) to Fractional Inspired O2 (SpO2/FiO2)
Duration of Intubation
Duration of Mechanical Ventilation
+20 more
Other outcome measures
Activity of prostaglandin D2
Concentration of BGE-175
Measure of Inflammation Markers
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BGE-175Experimental Treatment1 Intervention
BGE-175 tablet to be taken by mouth once a day for 14 days
Group II: PlaceboPlacebo Group1 Intervention
Placebo tablet to be taken by mouth once a day for 14 days

Find a Location

Who is running the clinical trial?

BioAge Labs, Inc.Lead Sponsor
3 Previous Clinical Trials
16 Total Patients Enrolled
Richard G Wilkerson, MDPrincipal InvestigatorUniversity of Maryland Medical Center
2 Previous Clinical Trials
120 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure
2021. "Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04705597.
~48 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top